Kobo Biotech Invites Expression of Interest for Acquisition

Kobo Biotech Ltd., a customer-centric manufacturer of Active Pharmaceutical Ingredients (API) based on Fermentation Technology, has republished its invitation for Expression of Interest (EOI). The company operates in Solapur with a land parcel at Hyderabad and a corporate office at Mumbai. The last date for submitting the EOI is 25-09-2025. The majority of the fixed assets are located at the factory site in Solapur and Hyderabad. The company's installed capacity is 2300 TPA. There were no main products or services sold in the last financial year. The last available financial statements are for the FY 2022-23. The eligibility criteria for resolution applicants can be obtained by sending an email to cirp.kobobiotech@gmail.com. The last date for receipt of expression of interest is 25-09-2025.